IMBA is committed to providing a safe, productive, and inclusive work environment where all employees can flourish. This includes the promotion of equitable opportunities regarding professional development and support, representation in positions of responsibility and leadership, as well as equal pay and benefits for employees in similar positions.
Together, the Institute of Molecular Biotechnology (IMBA), the Gregor Mendel Institute of Molecular Plant Biology (GMI), and the Research Institute of Molecular Pathology (IMP) have created an action-based Equity, Diversity, and Inclusion Plan covering the period from 2022 to 2025. The plan aims to bring equity, diversity, and inclusion to the foreground, fostering an environment in which any individual or group feels supported, respected, and valued, and monitor progress toward more equity and inclusion at our respective institutes.
IMBA aims to mainstream equity and inclusion and supports the activities of the volunteer Equity, Diversity, and Inclusion (EDI) group on campus. The EDI group organises events such as seminars and social activities, but also advocates a work environment that is more inclusive of underrepresented groups.